Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel class of medications, orexin receptor antagonists, in the treatment of insomnia – critical appraisal of suvorexant
Sarah L. Anderson, Jessica Norman
Nature and Science of Sleep (2016) Vol. Volume 8, pp. 239-247
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Insomnia in the Elderly: A Review
Dhaval Patel, Joel Steinberg, Pragnesh Patel
Journal of Clinical Sleep Medicine (2018) Vol. 14, Iss. 06, pp. 1017-1024
Open Access | Times Cited: 505
To eat or to sleep: That is a lateral hypothalamic question
Elda Arrigoni, Melissa J. Chee, Patrick M. Fuller
Neuropharmacology (2018) Vol. 154, pp. 34-49
Closed Access | Times Cited: 115
Orexin Receptor Antagonists as Emerging Treatments for Psychiatric Disorders
Ying Han, Kai Yuan, Yongbo Zheng, et al.
Neuroscience Bulletin (2019) Vol. 36, Iss. 4, pp. 432-448
Open Access | Times Cited: 77
Sleep interventions and glucose metabolism: systematic review and meta-analysis
Vallari Kothari, Zulma Cardona, Naricha Chirakalwasan, et al.
Sleep Medicine (2020) Vol. 78, pp. 24-35
Closed Access | Times Cited: 51
Sleep dysregulation in binge eating disorder and “food addiction”: the orexin (hypocretin) system as a potential neurobiological link
Jacqueline B. Mehr, Deborah Mitchison, Hannah E. Bowrey, et al.
Neuropsychopharmacology (2021) Vol. 46, Iss. 12, pp. 2051-2061
Open Access | Times Cited: 46
Hypnotic prescription trends and patterns for the treatment of insomnia in Japan: analysis of a nationwide Japanese claims database
Shoki Okuda, Zaina P. Qureshi, Yukiko Yanagida, et al.
BMC Psychiatry (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 18
Suvorexant, a Novel Dual Orexin Receptor Antagonist, for the Management of Insomnia
Andrew Hogyu Han, Caroline R. Burroughs, Evan P. Falgoust, et al.
Health psychology research (2023) Vol. 10, Iss. 5
Open Access | Times Cited: 13
REM sleep deprivation induces endothelial dysfunction and hypertension in middle-aged rats: Roles of the eNOS/NO/cGMP pathway and supplementation with L-arginine
Jiaye Jiang, Zhongyuan Gan, Yuan Li, et al.
PLoS ONE (2017) Vol. 12, Iss. 8, pp. e0182746-e0182746
Open Access | Times Cited: 44
Orexin receptor antagonists for the treatment of insomnia and potential treatment of other neuropsychiatric indications
W. Joseph Herring, Thomas Roth, Andrew D. Krystal, et al.
Journal of Sleep Research (2018) Vol. 28, Iss. 2
Closed Access | Times Cited: 44
New approved and emerging pharmacological approaches to alcohol use disorder: a review of clinical studies
Kirsten C. Morley, Christina J. Perry, Joshua Watt, et al.
Expert Opinion on Pharmacotherapy (2021) Vol. 22, Iss. 10, pp. 1291-1303
Closed Access | Times Cited: 32
De-orphaning the marine natural product (±)-marinopyrrole A by computational target prediction and biochemical validation
Petra Schneider, Gisbert Schneider
Chemical Communications (2017) Vol. 53, Iss. 14, pp. 2272-2274
Closed Access | Times Cited: 39
Dual orexin receptor antagonists increase sleep and cataplexy in wild type mice
Carrie E. Mahoney, Takatoshi Mochizuki, Thomas E. Scammell
SLEEP (2019) Vol. 43, Iss. 6
Open Access | Times Cited: 30
Effectiveness of Raw, Natural Medical Cannabis Flower for Treating Insomnia under Naturalistic Conditions
Jacob M. Vigil, Sarah S. Stith, Jegason P. Diviant, et al.
Medicines (2018) Vol. 5, Iss. 3, pp. 75-75
Open Access | Times Cited: 30
Suvorexant maintenance enhances the reinforcing but not subjective and physiological effects of intravenous cocaine in humans
William W. Stoops, Justin C. Strickland, Kevin W. Hatton, et al.
Pharmacology Biochemistry and Behavior (2022) Vol. 220, pp. 173466-173466
Open Access | Times Cited: 15
Treating insomnia with medications
J.F. Pagel, Seithikurippu R. Pandi‐Perumal, Jaime M. Monti
Sleep Science and Practice (2018) Vol. 2, Iss. 1
Open Access | Times Cited: 27
G protein‐coupled receptors not currently in the spotlight: free fatty acid receptor 2 and GPR35
Graeme Milligan
British Journal of Pharmacology (2017) Vol. 175, Iss. 13, pp. 2543-2553
Open Access | Times Cited: 26
In vitro, in vivo and ex vivo demonstration of the antitumoral role of hypocretin-1/orexin-A and almorexant in pancreatic ductal adenocarcinoma
Stéphanie Dayot, Daniela Speisky, Anne Couvelard, et al.
Oncotarget (2018) Vol. 9, Iss. 6, pp. 6952-6967
Open Access | Times Cited: 25
Acute cognitive effects of the hypocretin receptor antagonist almorexant relative to zolpidem and placebo: a randomized clinical trial
Thomas C. Neylan, Anne Richards, Thomas J. Metzler, et al.
SLEEP (2020) Vol. 43, Iss. 10
Open Access | Times Cited: 22
Deciphering Post-Stroke Sleep Disorders: Unveiling Neurological Mechanisms in the Realm of Brain Science
Pinqiu Chen, Wenyan Wang, Weikang Ban, et al.
Brain Sciences (2024) Vol. 14, Iss. 4, pp. 307-307
Open Access | Times Cited: 2
Pharmacological interventions targeting α-synuclein aggregation triggered REM sleep behavior disorder and early development of Parkinson's disease
Lida Du, Xiaoli He, Xiaonuo Fan, et al.
Pharmacology & Therapeutics (2023) Vol. 249, pp. 108498-108498
Closed Access | Times Cited: 6
Possible neuronal mechanisms of sleep disturbances in patients with autism spectrum disorders and attention-deficit/hyperactivity disorder
Jun Kohyama
Medical Hypotheses (2016) Vol. 97, pp. 131-133
Closed Access | Times Cited: 19
Induction of narcolepsy-like symptoms by orexin receptor antagonists in mice
Mahesh K. Kaushik, Kosuke Aritake, Yoan Chérasse, et al.
SLEEP (2021) Vol. 44, Iss. 8
Open Access | Times Cited: 15
Effect of suvorexant on nighttime blood pressure in hypertensive patients with insomnia: The SUPER‐1 study
Kazuomi Kario, Koichiro Yamasaki, Kazuro Yagi, et al.
Journal of Clinical Hypertension (2019) Vol. 21, Iss. 7, pp. 896-903
Open Access | Times Cited: 16
Effectiveness of suvorexant versus benzodiazepine receptor agonist sleep drugs in reducing the risk of hip fracture: Findings from a regional population-based cohort study
Ryozo Yoshioka, Seiichiro Yamamoto, Eiji Nakatani
PLoS ONE (2023) Vol. 18, Iss. 4, pp. e0284726-e0284726
Open Access | Times Cited: 5
Assessment of Switching to Suvorexant versus the Use of Add-on Suvorexant in Combination with Benzodiazepine Receptor Agonists in Insomnia Patients: A Retrospective Study
Masakazu Hatano, Hiroyuki Kamei, Risa Inagaki, et al.
Clinical Psychopharmacology and Neuroscience (2018) Vol. 16, Iss. 2, pp. 184-189
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top